For research use only
| Cat No. | ABC-TC0378 |
| Product Type | Mouse Liver Cancer Cell Lines |
| Species | Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Product Code | HEPCBR-1W, HEP CBR 1W, HEP-CBR1W |
HEP-CBR-1W is a murine hepatocellular carcinoma cell line induced by NDEA injection in C3H/HE mice, useful for liver cancer models and drug evaluation.
HEP-CBR-1W was derived from primary hepatocellular carcinoma tissue in C3H/He mice induced by a single intraperitoneal injection of N-nitrosodiethylamine (NDEA), providing a highly controlled experimental model that closely mimics the development and progression of liver cancer in vivo. This cell line is ideal for studying the molecular and cellular mechanisms underlying hepatocarcinogenesis, including gene expression changes, signaling pathway alterations, and tumor microenvironment interactions. It also offers a valuable platform for screening and evaluating potential anti-liver cancer compounds. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HEPCBR-1W, HEP CBR 1W, HEP-CBR1W |
| Species | Mouse |
| Cat.No | ABC-TC0378 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Liver Cancer Cell Lines |
HEP-CBR-1W cells serve as a hepatic model for studies on liver cancer progression, metabolism of xenobiotics, and oxidative stress response. They express important liver enzyme markers and enable investigation of bile acid signaling, lipid metabolism, and hepatocyte-specific drug responses. This cell line is ideal for in vitro screening of liver-targeted therapeutics and mechanistic study of carcinogenesis.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
